Death at 2 years · people with CKD
Uric acid lowering therapies (UAR) showed no clear difference in death at 2 years compared with placebo, no treatment or usual care (low certainty).
1 finding from 1 review
Dialysis · people with CKD
Uric acid lowering therapies (UAR) showed no clear difference in dialysis at 2 years compared with placebo, no treatment or usual care (low certainty).
1 finding from 1 review
Creatinine level · people with CKD
1 finding from 1 review
eGFR or creatinine clearance (mL/min/1.73m²) · people with CKD
1 finding from 1 review
Cardiovascular events · people with CKD
Uric acid lowering therapies (UAR) showed no clear difference in cardiovascular events compared with placebo, no treatment or usual care (low certainty).
1 finding from 1 review
Serum UA · people with CKD
1 finding from 1 review
Recurrent stroke of any type · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) probably leads to lower recurrent stroke of any type compared with placebo or no treatment (moderate certainty).
2 findings from 1 review
Stroke, myocardial infarction, or vascular death · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in major vascular event (composite of non‐fatal stroke, non‐fatal… compared with placebo or no treatment (high certainty).
1 finding from 1 review
Myocardial infarction · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in myocardial infarction compared with placebo or no treatment (high certainty).
1 finding from 1 review
Deaths due to vascular events · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death by any cause · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in death by any cause compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Dementia · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in dementia compared with placebo or no treatment (high certainty).
1 finding from 1 review
Preterm birth · pregnant women presenting for routine prenatal care
Lower genital tract infection screening probably leads to lower preterm birth less than 37 weeks compared with no screening (moderate certainty).
1 finding from 1 review
Preterm low birthweight (below or equal 2500 g) · pregnant women presenting for routine prenatal care
Lower genital tract infection screening probably leads to lower preterm low birthweight (below or equal 2500 g) compared with no screening (moderate certainty).
1 finding from 1 review
Preterm very low birthweight (below or equal 1500 g) · pregnant women presenting for routine prenatal care
Lower genital tract infection screening probably leads to lower preterm very low birthweight (below or equal 1500 g) compared with no screening (moderate certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · patients with preterm infants
1 finding from 1 review
Proportion of infants having at least one episode of low temperature requiring overhead heater use · patients with preterm infants
Transfer from incubator to cot at lower showed no clear difference in proportion of infants having at least one episode of low temperature… compared with higher body weight (high certainty).
1 finding from 1 review
Proportion of infants having at least one episode of returning to incubator · patients with preterm infants
Transfer from incubator to cot at lower showed no clear difference in proportion of infants having at least one episode of returning to… compared with higher body weight (moderate certainty).
1 finding from 1 review
Duration from transfer to cot to discharge home (days) · patients with preterm infants
1 finding from 1 review
Postmenstrual age at discharge · patients with preterm infants
1 finding from 1 review